PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE
Roberto Bernardo Escudero,John Claude Savoir Vilboeuf
申请号：
US13885629
公开号：
US20150150953A1
申请日:
2011.11.15
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to a pharmaceutical formulation or composition in the form of a tablet, coated tablet, capsule or powder tor reconstitution, for use in irritable bowel syndrome, comprising an intestinal motility modifier and enzyme α-D-galactosidase.
